Clinical Trial Update: Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intrathecal ziconotide for neuropathic and cancer-related pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Pain
• Intractable Pain
• Neuropathic Pain

Drugs mentioned

• Ziconotide (ziconotide)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Pain, Neuropathic Pain | Phase 2 | Status: UNKNOWN